The Hospice Advanced Dementia Symptom Management and Quality of Life Trial

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

83 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-02-11

Study Completion Date

2019-06-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Alzheimer's Disease and Related Disorders (dementia) are a group of serious life limiting illness that cause significant challenges to our public health system, with significant illness burden for both the person with dementia and the caregiver. At the end of life, over 230,000 persons with dementia annually are cared for in hospice, yet hospice agencies are ill prepared to care for this population and often resort to inappropriate pharmacologic measures such as antipsychotics that reduce quality of life rather than improve it. This study will therefore through its two phases refine and then implement, using a pragmatic stepped wedge trial design, the Dementia Symptom Management at Home Program Hospice Edition, with the goal improving quality of care for the person with dementia and their caregiver, reducing antipsychotic use, and increasing bereaved caregiver satisfaction in the hospice setting.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Hospice Advanced Dementia Symptom Management and Quality of Life Trial (HAS-QOL)

NCT04175977

Dementia

COMPLETED NA

The Dementia Symptom Management at Home Program Hospice Edition

NCT03352791

Dementia

TERMINATED NA

The Dementia Symptom Management at Home Program

NCT02482623

Dementia

WITHDRAWN NA

Dementia Symptom Management at Home Program

NCT03255967

Dementia

COMPLETED NA

Pilot Testing Dementia-Enhanced Training and Tool for Home Hospice Clinicians

NCT05719077

Alzheimer's Disease and Related Dementias

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dementia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Advanced Demential Patients

Group Type EXPERIMENTAL

Dementia symptom management at home hospice edition

Intervention Type BEHAVIORAL

Quality assurance performance improvement program

Hospice IDT Members

Group Type EXPERIMENTAL

Education and Training

Intervention Type BEHAVIORAL

Education and training

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dementia symptom management at home hospice edition

Quality assurance performance improvement program

Intervention Type BEHAVIORAL

Education and Training

Education and training

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must have dementia as primary diagnosis for admission to hospice
* Must be newly admitted to a participating hospice
* Must be 50 years or older

Clinicians:

* Must be a skilled clinician or home health aide who provides care through an eligible home health agency
* Must be 18 years or older